The Study
Selenomethionine as a dual-mechanism ferroptosis inhibitor: selenium-supply-driven GPX4 biosynthesis beyond transsulfuration and reductive-capacity-mediated ROS scavenging independent of GPX4 activity
This study is like a scientist playing with cells in a dish and one sick mouse to see if a vitamin-like chemical might help. It shows a possible pattern, but it’s not proof — it’s just a first peek. We can’t say it works in people or that it causes the effect.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Selenomethionine is a selenium-containing compound that helps cells avoid a type of death called ferroptosis, which happens when fats in cell membranes get damaged by rust-like reactions.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 513 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this suggests taking selenomethionine could help protect kidneys from damage caused by drugs like cisplatin, which is used in cancer treatment.
- 2It works two ways: (1) It helps make more GPX4 protein (a cell’s rust-fighting tool), and (2) Even without GPX4, it directly mops up harmful rust-causing molecules (ROS).
- 3In mice, it lowered kidney damage markers by 30–50%.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Cell Death & Disease
Year
2026
Authors
Chaoyi Xia, Xue Sun, Junyi Shao, Jingshu Min, Chong Wei, Feiyang Zhao, Caiyun Fu, Qiang Zhang
Related Content
Claims (6)
Selenium is a nutrient necessary for the body to produce glutathione, a molecule that helps lower levels of oxidative stress and inflammation in cells.
In mice with kidney injury caused by cisplatin, taking selenomethionine by mouth lowers levels of biomarkers associated with kidney damage and improves tissue appearance under a microscope, which is linked to higher levels of the enzyme GPX4 in the kidneys.
Selenomethionine, a form of selenium, can still prevent cell damage and death in human cells even when the GPX4 protein is completely removed, suggesting it blocks a type of cell death called ferroptosis through a different pathway than previously thought.
Selenomethionine raises the levels of the GPX4 protein in specific human cells grown in the lab when those cells are stressed by lack of cystine or exposure to RSL3, and this effect occurs even when two key enzymes in the transsulfuration pathway are blocked.
Selenomethionine decreases markers of oxidative damage and cell death in human cancer cells under conditions that trigger ferroptosis, such as exposure to RSL3 or lack of cystine.
Selenomethionine can neutralize reactive oxygen species by undergoing a chemical reaction that produces selenomethionine sulfoxide, and this process reduces ferroptosis without requiring the synthesis of new proteins.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.